FINVASIA MUTUAL FUNDS

DSP Healthcare Fund - Direct (G)

by:DSP Healthcare Fund

Invest

Statistics

  • AUM

    1195.58Cr

  • Returns

    1y : 14.66%
    3y : 21.69%
    5y : 25.59%
    Since Inception : 24.40%

  • NAV

    40.67 ( as on 02-05-2025)

  • Risk

    Very High

  • Last Dividend Paid

    0.00

  • Expense Ratio

    0.00%

  • Benchmark

    S&P BSE Healthcare TRI

  • Exit Load

    <= 12 months - 1%.

3m6m1y2yALL
Fund Manager Name
Vinit Sambre
Qualification
B.Com., FCA
Designation
FUND MANAGER
Experience
Prior to joining DSP BlackRock he was associated with DSP Merrill Lynch Ltd.(Nov 2005 to Jun 2007), IL & FS Investsmart Ltd. (Dec 2002 to Oct 2005), Unit Trust of India Investment Advisory Services Ltd.(Jun 2000 to Dec 2002), Kisan Ratilal Choksey Shares
Remarks

    Holdings

  • Company

    Sector

    Percentage held

  • Sun Pharma.Inds.

    Pharmaceuticals & Biotechnology

    10.59%

  • Suven Pharma

    Pharmaceuticals & Biotechnology

    8.49%

  • Cipla

    Pharmaceuticals & Biotechnology

    8.20%

  • Ipca Labs.

    Pharmaceuticals & Biotechnology

    8.14%

  • Divi's Lab.

    Pharmaceuticals

    6.34%

  • Globus Medical Inc

    Healthcare Equipment & Supplies

    5.70%

  • Illumina Inc

    Healthcare Services

    4.78%

  • Alembic Pharma

    Pharmaceuticals & Biotechnology

    4.54%

  • Zydus Lifesci.

    Pharmaceuticals & Biotechnology

    4.39%

  • Gland Pharma

    Pharmaceuticals & Biotechnology

    4.38%

  • Apollo Hospitals

    Healthcare Services

    4.07%

  • Dr Reddy's Labs

    Pharmaceuticals & Biotechnology

    4.04%

  • Suven Life Scie.

    Pharmaceuticals & Biotechnology

    3.92%

  • Torrent Pharma.

    Pharmaceuticals

    3.88%

  • Concord Biotech

    Pharmaceuticals & Biotechnology

    3.87%

  • Sai Life

    Pharmaceuticals & Biotechnology

    3.55%

  • Laurus Labs

    Pharmaceuticals & Biotechnology

    3.50%

  • J B Chem & Pharm

    Pharmaceuticals

    3.28%

  • Vijaya Diagnost.

    Healthcare Services

    3.22%

  • Indoco Remedies

    Pharmaceuticals & Biotechnology

    3.17%

  • Dr Lal Pathlabs

    Healthcare

    3.06%

  • Kovai Medical

    Healthcare Services

    2.95%

  • Pfizer

    Pharmaceuticals & Biotechnology

    2.81%

  • Other Foreign Equity

    Healthcare Services

    2.75%

  • Intuitive Surgical

    Healthcare Services

    2.70%

  • Intuitive Surgical Inc

    Healthcare Equipment & Supplies

    2.51%

  • P & G Health Ltd

    Pharmaceuticals & Biotechnology

    2.49%

  • Jubilant Life

    Pharmaceuticals

    2.33%

  • Abiomed Inc

    Healthcare Equipment & Supplies

    2.26%

  • Syngene Intl.

    Healthcare Services

    1.82%

  • TREPS

    NA

    1.71%

  • Unichem Labs.

    Pharmaceuticals & Biotechnology

    1.64%

  • Max Healthcare

    Healthcare Services

    1.52%

  • ILLUMINA

    Pharmaceuticals

    1.50%

  • Emcure Pharma

    Pharmaceuticals & Biotechnology

    1.49%

  • Taro Pharmaceutical Industries

    Pharmaceuticals & Biotechnology

    1.35%

  • ICICI Lombard

    Insurance

    1.29%

  • Narayana Hrudaya

    Healthcare Services

    1.22%

  • Aarti Drugs

    Pharmaceuticals & Biotechnology

    1.11%

  • Abbott India

    Pharmaceuticals

    1.02%

  • Abbott Laboratories

    Pharmaceuticals & Biotechnology

    0.92%

  • Ajanta Pharma

    Pharmaceuticals

    0.87%

  • Net CA & Others

    NA

    0.81%

  • Alkem Lab

    Pharmaceuticals & Biotechnology

    0.63%

  • Global X Funds - Global X Geno

    Foreign Security

    0.61%

  • Lupin

    Pharmaceuticals & Biotechnology

    0.57%

  • Medplus Health

    Retailing

    0.48%

  • Jupiter Life Lin

    Healthcare Services

    0.45%

  • Mankind Pharma

    Pharmaceuticals & Biotechnology

    0.44%

  • Max India Ltd

    Healthcare Services

    0.40%

  • Reverse Repo

    NA

    0.26%

  • Thyrocare Tech.

    Healthcare Services

    0.07%

  • Grail Inc

    Healthcare Services

    0.04%

Scheme Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.

AMC Details

  • Name

    DSP Investment Managers Private Ltd

  • Email Id

    service@dspim.com

  • Website Url

    www.dspim.com

  • Address

    The Ruby, 25th Floor, 29, SenapatiBapat Marg, Dadar (West),Mumbai - 400028.

  • Telephone Number

    022-66578000

  • Fax Number

    022-66578181

Fund Details

  • Scheme Type

    Growth

  • Category

    Equity - Diversified

  • Launch Date

    2018-11-12

  • Fund Type

    Open-Ended

  • Fund Manager

    Vinit Sambre

  • Min. Investment (One Time)

    500

  • Min. Investment (SIP)

    500

  • AMFI Code

    145454

  • ISIN Code

    INF740KA1LG1